First human tests for potential lung disease treatment
NCT ID NCT05662033
Summary
This early-stage study aimed to check the safety and see how the body processes a new drug called AZD6793. It involved healthy volunteers and a small group of people with moderate-to-severe COPD, a chronic lung disease. The main goal was to understand side effects and how the drug moves through the body after being taken as a liquid or a pill.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Harrow, HA1 3UJ, United Kingdom
-
Research Site
Wythenshawe, M23 9QZ, United Kingdom
Conditions
Explore the condition pages connected to this study.